𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genetically determined sparteine oxidation polymorphism in a Polish population

✍ Scribed by K. Orzechowska-Juzwenko; J. Pawlik; P. Niewiński; P. Milejski; J. Dembowski; J. Turek; A. Goździk; L. Swiebodzki; Z. Hora


Publisher
Springer
Year
1994
Tongue
English
Weight
259 KB
Volume
46
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

✦ Synopsis


The genetic oxidation polymorphism was determined in 160 healthy Polish volunteers from the southwest of Poland (Wroctaw region), using sparteine as a model drug. The results of a Polish population study revealed a bimodal distribution of the sparteine metabolic ratio and showed the existence of two oxidation phenotypes designated as extensive and poor metabolizers. The frequency of poor metabolizers in our study (8.8 %) compares well with most results of poor oxidation metabolizers in Caucasian populations.


📜 SIMILAR VOLUMES


Debrisoquine oxidation polymorphism in a
✍ M. E. Veronese; S. McLean 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 389 KB

The debrisoquine hydroxylation phenotype was studied in 152 unselected healthy Tasmanian subjects, who were mostly Caucasians of British ancestry. Following a 10 mg oral dose of debrisoquine (D), the ratio of D/4-hydroxydebrisoquine excreted in 8-h urine (metabolic ratio, MR) was determined. MR valu

Oxidative polymorphism of dextromethorph
✍ F. Nsabiyumva; Y. Furet; E. Autret; A. P. Jonville; M. Breteau 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 258 KB

The wide availability, metabolism by the same cytochrome P450 as debrisoquine and, above all, the inocuity of dextromethorphan (DMP) favour the frequent choice of this drug as the test substance in determining oxidation phenotypes. 100 healthy Burundian volunteers (94 m and 6 f) in this study ingest

PHARMACOKINETICS AND POLYMORPHIC OXIDATI
✍ Naomi Nagai; Takashi Kawakubo; Fumiyo Kaneko; Mika Ishii; Raito Shinohara; Yukih 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 676 KB

The plasma concentration and cumulative urinary excretion over 34h of dextromethorphan, free and conjugated dextrorphan, and 3-hydroxymorphinan were determined in seven healthy Japanese subjects after oral administration of 30mg dextromethorphan hydrobromide. Conjugated metabolites were extensively